Mental Health Clinics in Houghton Lake, MI Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Blue Skies Counseling Network, Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 234 Radcliff Dr, Houghton Lake, MI 48629 Phone: 989-390-4143 |
Nomi Counseling And Assessment Services Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1821 W Houghton Lake Dr Ste C, Houghton Lake, MI 48629 Phone: 231-886-8295 |
Harris Counseling And Support Services Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1960 W Houghton Lake Dr Ste 2, Houghton Lake, MI 48629 Phone: 989-372-4346 |
News Archive
Drug used to treat dizziness may slow down growth of triple-negative breast cancer
Screening Food and Drug Administration approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease.
London-led research looks at data that shows decline in post-anaesthetic deaths
A team of researchers led by London's Dr. Daniel Bainbridge have compiled data from 87 studies worldwide that shows post-anaesthetic deaths have declined as much as 90 percent since before the 1970s. During the same period, the risk of dying from any cause within 48 hours of surgery has decreased by 88 percent. The study covered outcomes in both developed and developing countries, with the findings published in the current issue of the high-profile journal The Lancet.
Articles examine use of mobile phones for global health
The Economist examines how mobile phones could be used to detect the spread of diseases worldwide. According to the Economist, "[t]he world's 4 billion mobile phones could be turned into sensors on a global data-collection network" and aid workers, engineers and several other professionals "are now building systems that use handsets to sense, monitor and even predict population movements, environmental hazards and public-health threats."
Increased risk of ovarian cancer witnessed in women taking hormone therapy
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling
AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.
› Verified 5 days ago